Shire to make genetic disease drug itself to secure supply supriya kashyap kashyap28 Oct 2017 9:15 AM ISTLondon: Shire will start making a genetic disease medicine itself after it was hit by supply problems, the London-listed firm said as it reported a...
CVC, others explore sale of drugmaker Alvogen supriya kashyap kashyap29 Sept 2017 9:17 AM ISTCVC Capital Partners and other private equity owners are exploring options for generic drugmaker Alvogen, including a sale, which could be valued at...
Concerned about Oxytocin misuse, CDSCO to outline regulatory control supriya kashyap kashyap28 Sept 2017 4:41 PM ISTNew Delhi: Concerned about Oxytocin misuse, CDSCO is now going to ensure Strict Regulatory control over Manufacture, sale, and distribution of...
Glenmark Pharma receives USFDA nod for skin lotion supriya kashyap kashyap28 Sept 2017 11:06 AM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for Desonide lotion used to treat skin rashes and...
Cheap drugs pay for Aurobindo Pharma as USFDA approvals surge supriya kashyap kashyap28 Sept 2017 10:16 AM ISTMumbai: While India’s largest pharmaceutical companies have seen drug approvals in the US slow overall, their research and development (R&D)...
Sanofi , Innovation Health Announces Pilot Program to Improve Care Delivery inType 2 Diabetes supriya kashyap kashyap28 Sept 2017 9:16 AM ISTFalls Church: Innovation Health, a unique partnership between two industry leaders, Inova and Aetna, and Sanofi, a global healthcare leader, announced...
Dabur plans subscription-based model for ayurvedic medicines supriya kashyap kashyap28 Sept 2017 9:07 AM ISTNew Delhi: Homegrown FMCG major Dabur is testing a subscription-based model for its ayurvedic medicines in the country, a senior company official...
Speciality segment to be a key growth driver for Sun Pharma: Dilip Shanghvi supriya kashyap kashyap27 Sept 2017 4:10 PM ISTNew Delhi: Drug major Sun Pharmaceutical Industries said it has identified speciality segment as one of the key drivers for growth going forward.The...
OrbiMed Asia invests $42.5 mn in Vivimed's API biz UQUIFA supriya kashyap kashyap27 Sept 2017 12:40 PM ISTNew Delhi: Drug firm Vivimed Labs has signed definitive agreements with healthcare firm OrbiMed Asia for investment of USD 42.5 million (nearly Rs 277...
Kyocera to expand medical product development supriya kashyap kashyap27 Sept 2017 9:16 AM ISTTokyo: Kyocera Corporation announced plans to expand operations at its new Medical Development Center which opened in Japan's Shiga Prefecture at the...
Need to revisit price cap on knee implants: MTaI supriya kashyap kashyap4 Sept 2017 10:30 AM ISTNew Delhi: Medical device makers body Medical Technology Association of India (MTaI) said it has asked the national drug pricing regulator NPPA to...
Abbott expands nutrition portfolio for Rare Metabolic Disorders in India supriya kashyap kashyap18 Aug 2017 10:00 AM ISTMumbai : Abbott, a leader in nutrition science research and development, has announced increased access to Abbott’s nutrition metabolic formulas...
